Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of BEST1 Vitelliform Macular Dystrophy — Stella

Home/Best Vitelliform Macular Dystrophy/Study of BEST1 Vitelliform Macular Dystrophy

View on ClinicalTrials.gov

Recruiting

Back to Best Vitelliform Macular Dystrophy trials

Study of BEST1 Vitelliform Macular Dystrophy

Trial locations(3 sites)

United States

Columbia University Irving Medical Center, New York, New York

France

Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts, Paris

Germany

Eberhard Karls University Tubingen, Tübingen

Key details

Sponsor

Columbia University

Collaborators

Universität Tübingen, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Enrollment target

~52 participants

Started

March 2021

Primary completion

May 2026

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.